📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis. (2018)

First Author: Tagalakis AD

Attributed to: The MRC Confidence in Concepts at UCL Fund 2015 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12951-018-0425-3

PubMed Identifier: 30482196

Publication URI: http://europepmc.org/abstract/MED/30482196

Type: Journal Article/Review

Volume: 16

Parent Publication: Journal of nanobiotechnology

Issue: 1

ISSN: 1477-3155